Astria Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
1.00 |
7.45 |
71.69 |
265.21 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
645.00% |
862.22% |
269.97% |
| Przychód (min) |
0.00 |
0.00 |
1.00 |
7.45 |
71.69 |
265.21 |
| Przychód (max) |
0.00 |
0.00 |
1.00 |
7.45 |
71.69 |
265.21 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-92.26 |
-129.32 |
-123.14 |
-132.35 |
-98.14 |
11.79 |
| Zysk netto % |
-inf% |
-inf% |
-12314.22% |
-1776.56% |
-136.91% |
4.45% |
| EPS (średnia) |
-1.69 |
-2.30 |
-2.33 |
-2.35 |
-1.75 |
0.21 |
| Liczba analityków (Przychody) |
0 |
0 |
7 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
4 |
5 |
6 |
6 |
3 |
4 |
| symbol |
ATXS |
ATXS |
ATXS |
ATXS |
ATXS |
ATXS |